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Abstract
Background Cue-reactivity is the array of responses that smokers exhibit when exposed to conditioned and contextual stimuli
previously associated to substance use. The difficulty to experimentally recreate the complexity of smokers’ spatial experience
and context requires more ecological models. Virtual reality (VR) creates a state of immersion close to reality allowing controlled
assessments of behavioral responses. To date, no studies investigated brain activation associated to smoking cue-reactivity in VR
using electroencephalography (EEG).
Aims To investigate whether a VR cue-reactivity paradigm (a) may increase smoking craving, (b) is feasible with EEG recording,
and (c) induces craving levels associated to EEG desynchronization.
Methods Smokers (N = 20) and non-smokers (N = 20) were exposed to neutral and smoking-related VR scenarios, without and
with smoking conditioned stimuli, respectively. EEG was recorded from occipital and parietal leads throughout the sessions to
assess alpha band desynchronization. Smoking and food craving and presence visual analogue scales (VAS) were assessed
during the session.
Results To be smoker, but not non-smoker, significantly influenced smoking craving VAS induced by smoking cue VR but not
by neutral VR. No significant food craving changes was observed during the VR sessions. The new finding was that EEG alpha
band power in posterior leads was significantly increased by the smoking context scenario only in smokers, and that the degree of
smoking (i.e., heavy vs. light) was significantly associated to this neurophysiological measure.
Conclusions This study demonstrated, for the first time, the feasibility of EEG recording in a VR setting, suggesting that EEG
desynchronization may be a neurophysiological marker of smoking cue-reactivity.
Keywords Craving . Cue reactivity . Electroencephalography . Smoking . Virtual reality . Visual analogue scale (VAS)
Introduction
Cue-reactivity is the vast array of responses that addicted peo-
ple exhibit when exposed to conditioned and contextual stim-
uli previously associated to substance use (Chiamulera
et al. 2017). Response to drug-related cue reactivity may be
physiological (Drummond et al. 2000), psychological (Niaura
et al. 1988) and behavioral (Rohsenow et al. 1991). Smoking
cue-reactivity has been widely described by anecdotal, eco-
logical, clinical, and experimental reports, and strongly related
to risk of relapse to drug-seeking, i.e., cigarette smoking. For
example, a smoking home suppresses the efficacy of pharma-
cotherapy for smoking cessation when compared to a
smoking-free domestic environment suggesting that both dis-
crete stimuli (such as objects) and living space could trigger
relapses (Gilpin et al. 2006).
Imaging studies in humans showed the activation of brain
areas involved in motivational, emotional, and cognitive pro-
cesses when subjects are exposed to a drug-related cue
(Yalachkov et al. 2012; McClernon et al. 2016). Smoking
cue reactivity has been investigated by electroencephalogra-
phy (EEG) studies , which showed greater alpha
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compared to neutral ones in smokers (Cui et al. 2013). Frontal
EEG activities have been reported to differ between smokers
and non-smokers (Knott et al. 2008a; Rass et al. 2016). Taken
together, these studies not only showed different EEG activa-
tion in smokers vs non-smokers, but also suggested that EEG
could be a sensitive neurophysiological marker of cue
reactivity.
The difficulty to recreate the complexity of smokers’ spatial
experience and the context in a laboratory setting needs more
ecological models. Virtual reality (VR), which creates a state of
immersion closer to reality, allowing the controlled measure of
neuropsychological and behavioral responses (Pericot-Valverde
et al. 2015), may create an ecological and realistic experimental
setting in human studies. For this reason, VR has been extensive-
ly used in drug and tobacco addiction, e.g., to explore smoking
withdrawal, craving and cue reactivity (Pericot-Valverde et al.
2015). Although these VR reports confirmed findings previously
demonstrated in traditional laboratory studies (i.e., cues presented
as pictures or videos), better characterization of the cue reactivity
phenomena triggered by VR simulation is needed. For instance,
one psychological measure of experience in VR is the sense of
presence (henceforth, presence), which was proposed to be relat-
ed to allocation of attentional resources (Witmer and Singer
1998; see also the debate in Slater 1999) and correlated to EEG
changes in sensorimotor integration areas (Vecchiato et al. 2015).
The exploration of EEG activity in a cue reactivity VR experi-
mental protocol may be a technically demanding issue. Indeed,
the application of the VR helmet and the EEG cap on the head of
the subjects and the eye, head, neck, and body movements asso-
ciated with VR space exploration may potentially lead to a num-
ber of artifacts. To date, no studies investigated craving-related
cortical activation for smoking in a VR ecological and controlled
context using EEG.
The present study was aimed to investigate (a) whether a cue-
reactivity paradigm may induce an increase in smoking craving
in a controlled VR condition, (b) the feasibility of EEG recording
in this experimental setting, and (c) if smoking craving level is
associated to a specific pattern of EEG desynchronization. To
these aims, smokers and non-smokers were exposed to a control
(i.e., no smoking-related cues) VR scenario and then to smoking-
related VR scenarios, with and without smoking conditioned
stimuli. EEG was recorded from occipital and parietal leads
throughout the VR scenarios to assess whether alpha band
desynchronization was associated to smoking craving. Food
craving and presence were also assessed during the session.
Materials and methods
Study design
Non-randomized study in two cohorts of smokers and non-
smokers exposed to control and then smoking-related cues
VR scenario on a fixed-block order procedure. These scenar-
ios were chosen to represent a prototypic context, i.e., a room
with the minimal number of office (control scenario), and
office and smoking elements (smoking cues: ashtray, smoke,
cigarette, pack of cigarette, cup of coffee; Fig. 1). The primary
endpoint was the assessment of cue reactivity as craving level
for smoking and food by using a visual analogue scale (VAS).
Sense of presence was also assessed by using a VAS scale.
Brain activation was measured by recording EEG during the
presentation of VR scenarios.
Subjects
Forty volunteers were recruited through online and paper ad-
vertisements, placed in the main gathering areas of the School
of Medicine, Verona University, Italy. The procedures and
potential risks associated to the experimental study were clear-
ly and fully explained to the subjects. Furthermore, they were
invited to read carefully and afterwards to personally fill out
and sign an informed consent document, prior to the experi-
mental sessions. The informed consent was in a language
understandable to the subjects and clearly presented by one
experimenter, who responded to all the questions raised by the
subjects. The statement could be withdrawn in every moment
and for every reason. The study was approved by the local
academic ethical committee for research in healthy volunteers
(Comitato di Approvazione per la Ricerca sull’Uomo, CARU,
protocol code 22/2018), and followed the principles of the
Declaration of Helsinki. The subjects’ data were collected
and stored in a limited-access computer system, located in
the Human Laboratory, Department of Diagnostic and
Public Health, University of Verona, Italy. Each participant
was given an identification code, formed by a number, sub-
ject’s initials, and date of birth to ensure the anonymity.
Inclusion criteria were as follows: (a) male or female, (b)
age 18–65 years, and (c) should smoke at least 10 cigarettes a
day, for at least the previous year (only for smoker group).
Exclusion criteria were as follows: (d) personal or familiar
history of seizures, (e) personal clinical history of cardiovas-
cular or chronic disease, (f) current pregnancy, (g) cardiac
pacemaker or any other metallic device or implant in the
head-neck district, except piercings or braces, and (h) active
therapy with psychotropic drugs, or use of psychoactive sub-
stances, which could interfere with the VAS or EEG mea-
sures. Inclusion and exclusion criteria were verified during
an interview led by one of the experimenters prior to the study.
Procedures
Subjects were welcomed in the Human Laboratory,
Department of Diagnostic and Public Health, University of
Verona, Italy. Smokers were requested not to smoke at least
1 h before the session. Smoking status was assessed by
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measuring the carbon monoxide (CO) expired concentration.
Participants were invited to take place on the workstation
chair, were instructed about the study procedures and risks,
and signed the informed consent, and the experimenters con-
firmed the absence of exclusion criteria. All participants were
instructed how to fill out the demographic and smoking ques-
tionnaires (smoker group only: smoking status-history assess-
ment, Fagerström Test for Nicotine Dependence).
A standard 32 channels elastic cap of the appropriate size
for the head of the patient was mounted.
The experimenters gave instructions on how the head-
mounted display worked and how to move in the VR environ-
ment. The experimenters helped the participant to wear the
head-mounted display and headphones (Fig. 2). Participants
were exposed to a 3-min VR scenario (neutral; a mountain
landscape) followed after a 2-min pause without VR display
by the 3-min VR office (control; non-smoking cues context)
and then, after another 2-min pause, by the 3-min VR office
and smoking cues (smoking context) containing conditioned
stimuli (a smoking cigarette in an ashtray, a pack of cigarette,
a coffee; Figs. 1, 3). The protocol was a fixed-block order
procedure as recommended for avoiding craving carry-over
effect (Sayette et al. 2010). Subjects were required not to do
any specific task in the VR scenarios; they were left free to
explore the surroundings with their head movement. At the
end of each scenario, subjects removed the Oculus Rift VR
display and filled out the smoking and food craving VAS
questionnaire, which was also filled before the VR sessions.
The presence questionnaire was filled after the neutral and at
the end of the experimental procedure after the smoking con-
text scenario. The study was a single session, lasting about
45 min.
Virtual reality tools
Oculus Rift is a VR head-mounted display, which comprises a
pair of eye goggles, positioned over the participant’s face,
developed by Oculus VR a division of Facebook Inc.
(Menlo Park, California, USA). The Rift is designed to pro-
vide a stereoscopic vision with a full 6 degrees of freedom
environment. Thanks to its rotational and positional tracking
system, Oculus Rift allows the subject to explore the scene by
moving the head and body. Participants also wore a pair of
headphones to simulate environmental sounds. VR scenarios
were created using the development platform Unity.
Questionnaires
The Smoking Status-History Assessment Questionnaire con-
sists of five questions about the current status and the smoking
history. The Fagerström Test for Nicotine Dependence is a
widely used and extensively validated questionnaire to test
the degree of nicotine dependence via tobacco smoking
(Heatherton et al. 1991). The Fagerström score was evaluated
according to Heatherton et al. (1991), where low dependence
is represented by score 0–2, low-to-moderate dependence by
score 3–4, moderate dependence by score 5–7, and high de-
pendence by score ≥ 8.
The 0–10 VAS for smoking and food craving was adapted
from Traylor et al. (2011). VAS for sense of presence was
adapted from Vecchiato et al. (2015). All the VASs were
scored before VR sessions (VAS1) and after the three scenar-
ios (VAS2-4).
EC50 Smokerlyzer
The expired CO concentration, a non-invasive method of
assessing smoking status, was measured by using the EC50
Smokerlyzer (Bedfont Instruments; Kent, UK). Breath CO
Fig. 2 Experimental setup. Participants wore a standard EEG elastic cap,
the virtual reality head-mounted display, and the headphones
Fig. 1 Screenshots of the virtual reality (VR) scenarios used in the study.
Participants were exposed to a 3-min VR scenario (neutral, a mountain
landscape; left panel), a 3-min VR office (control, non-smoking cues
context; middle panel), and a 3-min VR office and smoking cues
(smoking cue context containing conditioned stimuli; right panel)
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levels was expressed in parts per million (ppm) based on the
conversion of CO to carbon dioxide (CO2) over a catalytically
active electrode (Middleton et al. 2000).
EEG
EEG activity was recorded during VR sessions with a digital
Galileo NT (EB Neuro, Florence, Italy) system, using active
Ag/AgCl electrodes at 32 scalp sites according to the
International 10/10 system (ACNS 2006), i.e., 32 standard
channelsmounted on an elastic cap and twomastoid locations,
M1 and M2, which were used for off-line re-referencing. All
signals were digitized with a sample rate of 256 Hz. Offline,
the EEG signals were referenced to the mathematically linked
mastoids, and EEG and EOG were phase-shift-free filtered
using a 0.1–30 Hz band-pass filter and a notch (50 Hz) filter.
Impedance was kept below 10 KOhm.
Sample size
The sample size for this study was calculated using G*Power
software version 3.1.5.1 (Faul et al. 2009) with α = 0.05 and
power (1-β) = 0.8. The estimated sample size estimated was
20 participants for each group.
Statistical analysis
Statistical analyses were performed using the IBM SPSS ver-
sion 20.0 and the PRISM 6 software (GraphPad Software Inc.,
San Diego, CA, USA).
Two-way rm-ANOVA with between-group factor status
(two levels: non-smokers, smokers) and within-group factor
scenario (four levels: VAS1, VAS2, VAS3, VAS4) was
applied to smoking and food craving VAS, followed by post
hoc with Sidak’s test.
Two-way rm-ANOVA with between-group factor status
(two levels: non-smokers, smokers) and within-group factor
scenario (three levels: VAS2, VAS3, VAS4) was applied to
presence VAS measure, followed by post hoc with Sidak’s or
Dunnett’s tests.
EEG data were processed using the EEGLAB (Delorme
and Makeig 2004) version 14 software. Artifacts correction
was performed using baseline correction and independent
components analysis technique (ICA; Makeig et al. 1996).
Each EEG segment underwent Fast Fourier transform (FFT)
using a Hanning window of 10%. For each VR scenario, the
FFTs were averaged and alpha (7.75–13.75 Hz) band power
from O1, O2, P3, P4, and Pz electrodes was log10-trans-
formed. Three-way rm-ANOVA with between-group factor
status (two levels: non-smokers, smokers) and within-group
factor scenario (three levels: scenario1, scenario2, scenario3)
and electrode (five levels: O1, O2, P3, P4, and Pz) was applied
to alpha band power, and post hoc t test with Sidak’s test.
Subjects in the smoker group were further divided into light
and heavy smokers according to the number of daily smoked
cigarettes (< 10 and ≥ 10/day, respectively), and rm-ANOVA
was further performed with the between-group factor status2
(three levels: non-smokers, light smokers, heavy smokers).
For all the analyses, the statistical significance was set at
p < 0.05 (two-tailed).
Results
Demographics
The demographic data are reported in Table 1.
VAS1 VAS2 VAS3 VAS4
Fig. 3 Schematic diagram of the
study design. Each experimental
session lasted about 45 min,
including informed consent,
screening procedure, baseline
questionnaires, and virtual reality
(VR) session. Visual analogue
scale (VAS) for smoking craving,
food craving, and sense of pres-
ence was filled out after the VR
sessions. CX, context; CS, condi-
tioned stimuli, i.e., smoking cues;
VR-neutro, VR neutral scenario;
VR-CX +CS, VR smoking con-
text scenario
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Smoking craving
Two-way rm-ANOVA showed significant effect of status
(F[1.38] = 75.36; p < 0.0001), scenario (F[3.114] = 18.95;
p < 0.0001) and significant status × scenario interaction
(F[3.114] = 19.69; p < 0.0001). Post hoc within-group
comparisons showed that the smokers, but not the non-
smoker group, reported significantly higher craving score
at the last timepoint (VAS4) compared to the other
timepoints (VAS1 to VAS3; p < 0.0001 for all compari-
sons; Sidak’s test; Fig. 4). Post hoc between-group com-
parisons showed significant higher craving score in the
smokers vs. non-smoker groups for all timepoints
(VAS1 to VAS4; p < 0.0001 for all the comparisons;
Sidak’s test).
Two-way rm-ANOVA showed a significant effect of
s t a tus2 (F [2 .37 ] = 39 .61 ; p < 0.0001) , s cenar io
(F[3.111] = 29.91; p < 0.0001), and significant status2 ×
scenario interaction (F[6.111] = 10.03; p < 0.0001). Post
hoc within-group comparisons showed that the light
smokers and the heavy smokers, but not the non-smokers,
had significantly higher VAS4 craving score compared to
VAS1-3 (p < 0.0001 for all comparisons; Sidak’s test; Fig.
4). Post hoc between-group comparisons showed signifi-
cant higher craving score in the light smokers vs. non-
smokers and heavy smokers vs. non-smoker groups for
all timepoints (VAS1 to VAS4; p < 0.0001 for all the
comparisons; Tukey’s test; Fig. 4).
Food craving
Two-way rm-ANOVA showed a significant effect of sce-
nario (F[3.114] = 5.83; p < 0.001) but not of status
(F[1.38] = 0.02; NS) and no interaction (F[3.114] = 0.12;
NS). Post hoc within-group comparisons showed that the
smokers, but not the non-smokers, had significantly
higher VAS4 craving score compared to baseline VAS1
(p < 0.05; Dunnett’s test; Fig. 5). Post hoc between-group
comparisons yielded no significant differences at all
timepoints (NS; Sidak’s test).
Table 1 Demographic characteristics of the non-smoker and smoker
groups
Non-smokers Smokers Total
Characteristic N % N % N %
Sex
Male 10 50.0 13 65.0 23 57.5
Female 10 50.0 7 35.0 17 42.5
Age
≤ 25 19 95.0 19 95.0 38 95.0
26–30 1 5.0 1 5.0 2 5.0
Highest degree awarded
High school diploma 20 100.0 18 90.0 38 95.0
Bachelor’s degree - - 2 10.0 2 5.0
Years of smoking
≤ 10 - - 20 100.0
Number of cigarettes/day
< 10 - - 13 65.0
10–15 - - 6 30.0
> 15 - - 1 5.0
Fagerström score
Low dependence - - 18 90.0
Low-to-moderate dependence - - 1 5.0
Moderate dependence - - 1 5.0
High dependence - - - -
Age, mean = 22.78, SD = 1.98. No subject of the non-smoker group re-
ported to be an ex-smoker. The Fagerström score was evaluated accord-
ing to Heatherton et al. (1991), where low dependence is represented by
score 0–2, low-to-moderate dependence by score 3–4, moderate depen-
dence by score 5–7, and high dependence by score ≥ 8







































Fig. 4 Smoking craving. Left panel. Smoking craving score in the non-
smokers (open columns;N = 20) and the smokers (solid columns;N = 20)
groups at the different timepoints (VAS1 to VAS4). Right panel.
Smoking craving score in the non-smokers (open columns; N = 20), light
smokers (gray columns; N = 13), and heavy smokers (solid columns;N =
7) groups at VAS1 to VAS4. Data are expressed as mean + SEM.
****Significant within-group post hoc (p < 0.0001 vs. VAS1, VAS2,
and VAS3; Sidak’s test). Between-groups significant post hoc compari-
sons are reported in the main text
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Presence
Two-way rm-ANOVA showed significant effect of scenario
(F[2.76] = 4.53; p < 0.05), but not of status (F[1.38] = 1.70;
NS) and no significant interaction (F[2.76] = 1.43; NS). Post
hoc within-group comparisons showed that the smokers, but
not the non-smokers, had a slight but significant presence
score increase at VAS3 vs. VAS2 timepoint (p < 0.01;
Sidak’s s test; Fig. 6). Post hoc between-group comparisons
yielded no significant differences at all timepoints (NS;
Sidak’s test).
Two-way rm-ANOVA showed a significant main effect of
scenario (F[2.74] = 4.88; p < 0.01) but not of status2
(F[2.37] = 2.02; NS) and no interaction (F[2.74] = 0.70; NS).
Post hoc within-group comparisons showed a significant in-
crease of presence in the light smokers at VAS3 vs. VAS2
timepoint (p < 0.05; Sidak’s s test; Fig. 6). Post hoc between-
group comparisons showed a significantly lower presence
score at VAS2 when comparing heavy smokers to non-
smokers (p < 0.05; Dunnett’s test).
Alpha band power
Three-way ANOVA showed a significant main effect of elec-
trode (F[4.304] = 16.9; p < 0.001), and significant electrode ×
status (F[4.304] = 3.6; p = 0.008) and scenario × status
(F[2.304] = 4.5; p = 0.014) interaction on the log10 alpha band
power. Post hoc within-group comparisons showed signifi-
cantly higher alpha band power during scenario 3 in compar-
ison to scenario 2 in P4 (p = 0.002; Sidak’s test) and Pz
(p < 0.001; Sidak’s test) in the smokers, but not the non-
smokers (Fig. 7).
Three-way ANOVA showed a significant main effect of
electrode (F[4.296] = 16.4; p < 0.001), and significant elec-
trode × status (F[8.296] = 2.4; p = 0.019) and scenario × status
(F[4.296] = 3.7; p = 0.008) interaction on the log10 alpha band
power. Post hoc within-group comparisons showed signifi-
cantly higher alpha band power during scenario 3 in compar-
ison to scenario 2 in PZ (p = 0.003; Sidak’s test) in light
smokers only (Fig. 7).
Discussion
As expected, to be a smoker, but not a non-smoker, sig-
nificantly influenced smoking craving induced by expo-
sure to the smoking cue scenario (VAS4), but not by
neutral and control scenarios. The absence of increasing
smoking craving during the session when no smoking
cues were presented excluded that higher craving scores
at the end of the session was due to passage of time or to
pre-session cigarette craving carry-over effect. Our data
are in agreement with VR literature on smoking cue reac-
tivity (Lee et al. 2003; Baumann 2004; Baumann and











Fig. 5 Food craving. Food craving score in the non-smokers (open col-
umns; N = 20) and the smokers (solid columns; N = 20) groups at the
different timepoints (VAS1 to VAS4). Data are expressed as mean +






































Fig. 6 Sense of presence. Left panel. Presence scores in the non-smokers
(open columns; N = 20) and the smokers (solid columns; N = 20) groups
at different timepoints (VAS2 to VAS4). Right panel. Presence scores in
non-smokers (open columns; N = 20), light smokers (gray columns; N =
13), and heavy smokers (solid columns;N = 7) groups at VAS2 to VAS4.
Data are expressed as mean + SEM. *p < 0.05 and **p < 0.01 significant
within-group post hoc vs. VAS2; Sidak’s test. #Significant between-
groups post hoc (p < 0.05 vs. VAS2 in non-smokers; Dunnett’s test)
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Sayette 2006; García-Rodríguez et al. 2011) and smoking
context (Garcia-Rodriguez et al. 2012; Paris et al. 2011). To
be heavy or light smoker was not associated to differences in
smoking craving, suggesting that the number of daily smoked
cigarettes is not correlated to smoking cue reactivity under our
VR procedure. Furthermore, our results confirm the validity of
the model, since no significant food craving changes was ob-
served during the sessions. The small but significant increase
in the smoker group after the last scenario suggests however a
gradual increase in appetitive urges.
The increase of presence during the experimental session in
the smoker group could be due to a pre-existing lower presence
trait at baseline. This hypothesis is in line with data from a pre-
vious study, where we found a similar lower presence score in
smokers compared to non-smokers independent from type ofVR
scenario (unpublished data). This finding is however opposite in
direction to studies in alcohol (Bordnick et al. 2008) and cocaine
addicts (Rosenthal et al. 2007) that showed an increased presence
in addicts, whereas Gamito et al. (2014) did not observe any
significant interaction between smoking status and presence.
A new and interesting finding of the present study was
that EEG alpha band power in posterior leads was signifi-
cantly increased by the smoking context scenario only in
smokers, and that the level of smoking (i.e., heavy, light)
had a significant effect on this neurophysiological measure.
Some previous studies explored EEG in smokers and during
smoke cue-reactivity experimental protocols. Daily smokers
showed reduced resting delta and alpha EEG power (Rass
et al. 2016). Frontal theta band power was found to be de-
creased during smoking cue reactivity, similarly to a condi-
tion of withdrawal, in males with no change in frontal alpha
band power (Knott et al. 2008b). Frontal alpha EEG was
reported to be asymmetric (i.e., left frontal hypoactivation)
with cigarette-cue exposure, particularly in female smokers,
with both decreases and increases in brain state during
cigarette-cue exposure, influenced by depressed mood
(Knott et al. 2008a). A significant increase in beta power,
but no changes in delta and theta activity, between smoke-
related cue and neutral stimuli, together with reduction of
theta power in reward craving and increase in left posterior
alpha in withdrawal craving, was observed in smokers (Littel
et al. 2009). Finally, emotional and cigarette-related stimuli
were reported to induce less alpha power than neutral stimuli
in smokers (Cui et al. 2013). Comparison of our data to those
previously published is difficult, because of the differences
in study protocols, EEG leads and bands explored, and the
presence/absence of smoking withdrawal across studies. A
limitation of this study is that it was not possible to evaluate
the possible correlation between the increased alpha band in
posterior lead for smokers exposed to smoking context and
the presence level. Increased parietal alpha power has been
correlated to higher presence in VR (Pfurtscheller and Lopes
da Silva 1999; Kober et al. 2012), suggesting the involve-
ment of parietal areas in the sense of spatial presence. This
view is in keeping with evidence that egocentric spatial pro-
cessing in parietal areas is expression of body-centered visu-
al control of location (Baumgartner et al. 2006, 2008).
Another limitation stems from the limited range of






































































Fig. 7 EEG Alpha band power. Upper/central panel. Log10 alpha band
power in the non-smokers (open columns; N = 20) and smokers (solid
columns; N = 20) groups during 3-min VR mountain landscape scenario
(VR-neutro), 3-min VR non-smoking cues context office (VR-CX), and
3-min VR smoking cue context + conditioned stimuli (VR-CX + CS)
measured at P4 and Pz electrodes. Lower panel. Log10 alpha band power
in non-smokers (open columns; N = 20), light smokers (gray columns;
N = 13), and heavy smokers (solid columns; N = 7) measured at Pz elec-
trode. Data are expressed as mean + SEM. ***Significant within-group
post hoc (p < 0.01 vs. VR-CX; Sidak’s test)
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majority of them had low dependence impeding a compari-
son between participants with different dependence levels.
Indeed, the present study demonstrated, for the first time,
that EEG recording is feasible in a VR setting, suggesting that
EEG may represent a neurophysiological marker of smoking
cue-reactivity that may be used in a highly ecological exper-
imental setting.
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